KILL CicadaBio Announces Oral Presentation on CC-18, a First-in-Class GLP-1/ActRII Fusion Protein Designed for Muscle-Preservation Weight Loss, at ADA 2026

via Business Wire
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

 

CICADABIO CO. LTD requests that their press release NewsItemId: 20260605635242 issued June 5, 2026 “CicadaBio Announces Oral Presentation on CC-18, a First-in-Class GLP-1/ActRII Fusion Protein Designed for Muscle-Preservation Weight Loss, at ADA 2026” be killed. 

CC-18 is designed to address a growing challenge in obesity treatment: achieving meaningful weight loss while preserving muscle mass and improving long-term metabolic health.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article